Skip to Main Content Area
ABOUT
CONTACT
ADVERTISE
Home
News
Meeting Coverage
2011 ASCO Annual Meeting
Continuing Education
Supplements
Issue Archive
Editorial Board
Subscribe
Supplements
Risk Management: A new Era of Patient Safety
Advances in Treatment Options and Management of Chemotherapy-induced Nausea and Vomiting
Cutaneous and Peripheral T-Cell Lymphomas: The Latest in Treatment Advances and Management Strategies
ASH Highlights on Non-Hodgkin Lymphoma: A Payer's and Pharmacist's Perspective
Considerations in Non-Hodgkin's Lymphoma: Clinical Trial Updates
Considerations in Non-Hodgkin's Lymphoma: T-Cell Lymphomas
Conference Faculty Perspectives: Compendium From ASH, the XII International Myeloma Workshop, and the Pan Pacific Lymphoma Conference
Considerations in Non-Hodgkin's Lymphoma: Diffuse Large B-Cell Lymphoma
Conference Faculty Perspectives: Updates From the Pan Pacific Lymphoma Conference
Considerations in Non-Hodgkin's Lymphoma: Waldenstrom's Macroglobulinemia
1
2
3
next ›
last »
Reader Poll
How important is your knowledge of J-Codes to your practice as an oncology pharmacist?:
Extremely important
Moderately important
Neutral
Slightly important
Not important
Top 5 Most Read Articles
Voraxaze Approved by FDA to Lower High Blood Levels of Chemotherapy
New Breast Cancer Treatment Model Emerging as Standard of Care
FDA Issues New Boxed Warning and Contraindication for Adcetris
Parabens Discovered in Breast Tissue Samples
Highly Accurate New Test for Colorectal Cancer